Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
12/08/2005US20050272072 Ligand-dependent protein splicing
12/08/2005US20050272067 Compositions, splice variants and methods relating to cancer specific genes and proteins
12/08/2005US20050272066 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders
12/08/2005US20050272064 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control
12/08/2005US20050272060 Chimeric CrylE delta endotoxin and methods of controlling insects
12/08/2005US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2005US20050272056 Gene identification method
12/08/2005US20050272050 Receptor protein for identifying modulators to treat and prevent inflammatory, antherosclerotic and cancer disorders; wound healing agents
12/08/2005US20050272048 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
12/08/2005US20050272041 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling
12/08/2005US20050272035 Functional screening method
12/08/2005US20050272031 Viral variants and uses therefor
12/08/2005US20050272030 Nucleic acid constructs for gene expression
12/08/2005US20050271769 Enzyme
12/08/2005US20050271733 Particle delivery techniques
12/08/2005US20050271732 Delivery of bioactive substances to target cells
12/08/2005US20050271714 a cationic lipid; and a taxane in a lipid bilayer of the taxane crystal free liposome
12/08/2005US20050271690 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
12/08/2005US20050271688 Modified vaccinia ankara virus variant
12/08/2005US20050271687 Retrovirus-like particles made non-infectious by a plurality of mutations
12/08/2005US20050271686 glycoprotein cationic polypeptide as HIV vaccines; nontoxic
12/08/2005US20050271685 Cellular permissivity factor for viruses and uses thereof
12/08/2005US20050271683 Nucleic acid sequences encoding Ostertagia ostertagi proteins and parts of such nucleic acid sequences encode an immunogenic fragment of such proteins; for use in vaccines
12/08/2005US20050271682 Administering the chimeric protein, comprising at least a first and a second polypeptide, wherein the N-terminus of the chimeric protien comprises the first polypeptide, wherein the first polypeptide comprises Borrelia burgdorferi OspC and wherein second polypeptide comprises Borrelia burgdorferi OspA
12/08/2005US20050271681 Isolated FrpB nucleic acid molecule and vaccine
12/08/2005US20050271680 Using immunogenic proteins LigA and LigB from Leptospira in development of effective vaccines and antibodies; detection of pathogenic Leptospira infection in a mammal
12/08/2005US20050271678 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
12/08/2005US20050271664 Antibodies for inhibiting blood coagulation and methods of use thereof
12/08/2005US20050271659 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
12/08/2005US20050271655 Nogo receptor antagonists
12/08/2005US20050271654 Antibody purification
12/08/2005US20050271642 Genetically engineering organisms that produce proteins lethal to larvae of insects nucleotide sequences isolated from Bacillus popilliae encode two adjacent, putative genes; orf1 and cryhime; insecticides, larvicides, pesticides; beetles
12/08/2005US20050271638 BMP pathway methods and compositions
12/08/2005US20050271637 BMP-2 estrogen responsive element and methods of using the same
12/08/2005US20050271628 Negative-sense RNA virus vector for nerve cell
12/08/2005US20050271625 RAAV-neprilysin compositions and methods of use
12/08/2005US20050271624 Use of apoptosis inducing agents in the treatment of (auto) immune diseases
12/08/2005US20050271623 Reduction of dermal scarring
12/08/2005US20050271622 Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
12/08/2005US20050271621 Ablated slam-dependent entry
12/08/2005US20050271620 Herpes simplex virus complex
12/08/2005US20050271589 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors
12/08/2005DE10085485B4 Verfahren zur Detektion des Mutationsgens dspp des hereditären opalisierenden Dentins Method for the detection of the mutation gene DSPP of hereditary opalescent dentin
12/08/2005CA2822895A1 Influenza hemagglutinin and neuraminidase variants
12/08/2005CA2777821A1 Mhc molecule-binding tumor-associated peptides
12/08/2005CA2590553A1 Method for identifying pde5-modulators
12/08/2005CA2568013A1 Nuclease resistant double-stranded ribonucleic acid
12/08/2005CA2567952A1 Oral anti-protozoiasis vaccines based on transgenic plants
12/08/2005CA2567937A1 Viral and viral associated mirnas and uses thereof
12/08/2005CA2567720A1 Stable protein storage and stable nucleic acid storage in recoverable form
12/08/2005CA2567624A1 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
12/08/2005CA2567337A1 Methods for dynamic vector assembly of dna cloning vector plasmids
12/08/2005CA2566572A1 Gene-cassette for enhancement of protein production
12/08/2005CA2566498A1 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna
12/08/2005CA2566475A1 Fermentative production of fine chemicals
12/08/2005CA2566286A1 Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
12/08/2005CA2565793A1 Method and apparatus for bacterial transformation by electroporation with waveforms incorporating pulsed rf between 3 and 125 mhz
12/08/2005CA2565103A1 Peptide conjugated, inosine-substituted antisense oligomer compound and method
12/08/2005CA2565098A1 Treatment of neurodegenerative disease through intracranial delivery of sirna
12/08/2005CA2563926A1 Transgenic models of alzheimer's disease and uses thereof in the treatment of a variety of neurodegenerative diseases
12/08/2005CA2563613A1 Device for extracting biological molecules from tissue specimens
12/08/2005CA2563314A1 Fcyriib-specific antibodies and methods of use thereof
12/07/2005EP1602921A1 Apparatus and method for detecting bio molecule using inductance device
12/07/2005EP1602734A1 Dna amplification method and kit therefor
12/07/2005EP1602729A2 Methods for producing transgenic plants
12/07/2005EP1602728A1 Alcohol dehydrogenase gene of acetic acid bacterium
12/07/2005EP1602727A2 Novel erythromycins and process for their preparation
12/07/2005EP1602726A2 Human tachykinin-related splice variants and compositions thereof
12/07/2005EP1602725A2 Abasic-nucleotide containing enzymatic nucleic acid
12/07/2005EP1602724A1 Magnetic pigment
12/07/2005EP1602720A1 Process for producing foreign protein in escherichia coli
12/07/2005EP1602717A1 Plant and plant cell having been modified in cell multiplication and development/differentiation
12/07/2005EP1602669A1 Antibody against tumor specific antigen as target
12/07/2005EP1602668A1 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/07/2005EP1602666A1 Novel protein and its dna
12/07/2005EP1602380A1 Preventive/remedy for diseases in upper digestive tract
12/07/2005EP1601974A2 Differential megaplex immunoassay
12/07/2005EP1601967A2 Identification of antigen epitopes
12/07/2005EP1601966A2 Methods and compositions for purification of nucleic acid from a host cell
12/07/2005EP1601789A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
12/07/2005EP1601784A2 Multiple controls for molecular genetic analyses
12/07/2005EP1601783A2 Wheel motion control input device for animation system
12/07/2005EP1601779A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
12/07/2005EP1601776A2 Expression vectors comprising the mcmv ie2 promoter
12/07/2005EP1601775A1 Animal model for the fast identification of pharmaceutical active compounds in vivo
12/07/2005EP1601774A2 Gdc-2 genes conferring herbicide resistance
12/07/2005EP1601773A2 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine
12/07/2005EP1601772A1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
12/07/2005EP1601771A1 Subunits of the adenovirus fiber protein and uses thereof as vaccines
12/07/2005EP1601770A2 Streptococcus pyogenes antigens
12/07/2005EP1601769A1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism
12/07/2005EP1601768A2 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
12/07/2005EP1601767A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF EIF-5A1
12/07/2005EP1601766A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
12/07/2005EP1601765A2 Variants of enzymes of the alpha-amylase family
12/07/2005EP1601759A2 Expansion of renewable stem cell populations using modulators of pi 3-kinase
12/07/2005EP1601758A2 Polynucleotides and polypeptides in plants
12/07/2005EP1601695A1 Mcam inhibitors
12/07/2005EP1601694A2 Uses of il-23 agonists and antagonists; related reagents
1 ... 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 ... 4023